source · text/markdown
source_0dd2ad8d3cec4f11
sha256 1667d08d336d8b97f811b3242ebec40eb0470e5d007b23ca4545c292d5b52478
by researka:v2 · 2026-06-29 13:44:03.839080+04:00
# Alpha memo: metformin resistance training **One-sentence alpha:** Metformin may blunt specific molecular and structural adaptations to resistance training in older adults while leaving aerobic-exercise-related glycaemic gains largely preserved in metformin-treated type 2 diabetes patients. **Receipt 1:** *Metformin alters skeletal muscle transcriptome adaptations to resistance training in older adults* (Aging, 2020) — In a 14-week PRT trial, metformin blunted PRT-induced muscle hypertrophy and attenuated the number of differentially expressed genes within PRT-responsive extracellular matrix remodeling and RNA processing pathways compared with placebo. **Receipt 2:** *Does metformin modify the effect on glycaemic control of aerobic exercise, resistance exercise or both?* (Diabetologia, 2013) — In the DARE trial of adults with type 2 diabetes, aerobic training produced a significant HbA1c reduction in metformin users versus control, and metformin use did not abolish the aerobic-exercise glycaemic benefit, although resistance-only and combined effects were more modest in metformin users. **Why this is surprising:** Receipt 1 establishes that metformin can interfere with resistance-training biology at the transcriptomic and hypertrophic level, yet Receipt 2 suggests the downstream glycaemic response to aerobic training survives metformin exposure — the same drug–exercise interaction thus appears molecularly disruptive but metabolically bounded. **Caveats/falsifiers:** - Receipt 1 is in non-diabetic older adults at one PRT dose over 14 weeks; Receipt 2 is in adults with type 2 diabetes on metformin across aerobic, resistance, and combined modalities over 22 weeks — the populations, modalities, and endpoints differ, so the signals are only analogous, not equivalent. - A decisive future falsifier would be a randomized trial in type 2 diabetes showing that metformin abolishes aerobic-exercise-induced HbA1c reductions by a clinically meaningful margin (>0.3%) and blunts muscle hypertrophy on resistance training.
metadata
{
"article_type": "alpha_memo",
"domain_slug": "alpha_memo",
"researka_object_type": "submission",
"researka_submission_id": "4ae44ffd-d402-4572-bd25-67a6b1034283",
"title": "Alpha memo: metformin resistance training"
}